Vaccines for children
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30122D13471
- Awardee
-
Sanofi Vaccines US Inc. UEI NCXBGGQ8YTU9
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Children Solicitation · 75D30122R72134 · Posted Jan 7, 2022
- Last date to order 100% complete
- IDV ceiling
- $1,681,772,750.00
- Maximum order
- $1,680,760,750.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract IDV was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. as the prime contractor. It is an indefinite delivery, indefinite quantity (IDIQ) contract with a ceiling value of $1,681,772,750 for the procurement of up to 23 standard pediatric vaccines over a 1-year period of performance from April 1, 2022 to March 31, 2023. The vaccines will support the CDC's Immunization Awardees and Vaccine for Children (VFC) program, which provides immunizations to eligible children. The solicitation did not use any set-aside designations. Sanofi Pasteur will fulfill agency requirements by shipping the vaccines FOB destination to the 50 U.S. states and territories from its manufacturing facilities. This IDV leverages Sanofi Pasteur's capabilities as a leading producer of vaccines and pharmaceuticals to the federal government through various contract vehicles, including other IDIQ contracts, Indefinite Delivery Vehicles, and a Federal Supply Schedule.
The contracted vaccine products include standard pediatric immunizations such as DTaP, MMR, varicella, pneumococcal conjugate, and others with a minimum 12-month shelf life. Minimum and maximum order quantities are specified per vaccine type, ranging from 100 doses to 13 million doses. Federal excise taxes are also provided, varying from $0.75 to $4.50 per dose depending on the vaccine. The CDC sought to establish these IDIQ contracts to ensure a reliable supply chain and efficient fulfillment of vaccine requirements for its public health programs serving children across the United States.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$2,408 | |
| Funding Only Action | $48,281,052 | |
| Funding Only Action | $61,192,922 | |
| Funding Only Action | $64,397,110 | |
| Funding Only Action | $134,003,751 | |
| Original award | $177,420,659 |
Quick answers
Who was awarded contract 75D30122D13471?
75D30122D13471 was awarded to Sanofi Vaccines US Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2022.
How much is contract 75D30122D13471 worth?
75D30122D13471's own ceiling is $1,681,772,750. A single order can be worth up to $1,680,760,750.
Who can order from contract 75D30122D13471?
75D30122D13471 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30122D13471 competed?
The extent of competition for 75D30122D13471 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV